SCHEMBL29144827

SCHEMBL29144827

CC(C)(C)OC(=O)[C@H]1CC(F)CN1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.39
▸ PEPD P12955 1/20 0.39
▸ XPNPEP1 Q9NQW7 1/20 0.39
▸ CHRM2 P08172 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HSD11B1 P28845 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ PTPN1 P18031 1/20 0.34
▸ DPP4 P27487 4/20 0.34
▸ HTRA1 Q92743 1/20 0.34
▸ DPP8 Q6V1X1 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29827776 1.00 NR1H2 (0.39) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL29144815 1.00 NR1H2 (0.39) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL29947782 1.00 NR1H2 (0.39) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL19484833 1.00 NR1H2 (0.39) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL3552873 0.91 PEPD (0.48) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL476146 0.91 PEPD (0.48) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL2995724 0.91 PEPD (0.48) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL3554330 0.91 PEPD (0.48) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL3643891 0.91 PEPD (0.48) NR1H2PEPDXPNPEP1CHRM2CHRM1
SCHEMBL18591298 0.91 PEPD (0.48) NR1H2PEPDXPNPEP1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117255684-A Quinazolinamine derivatives as KRAS inhibitors 尼坎治疗公司 2023-12-19 — — CN disclosed
Send feedback